2-methylbutyryl-CoA dehydrogenase deficiency

Get in touch with RARE Concierge.

Contact RARE Concierge

2-methylbutyryl-CoA dehydrogenase deficiency

Synonyms: 2-methylbutyric aciduria | Developmental delay due to 2-methylbutyryl-CoA dehydrogenase deficiency | SBCAD deficiency | Short/branched-chain acyl-coA dehydrogenase deficiency

A rare organic aciduria characterized by impaired isoleucine degradation with increased plasma or whole blood C5 acylcarnitine levels (typically observed in newborn screening) and increased urinary excretion of N-methylbutyrylglycine. The condition is usually clinically asymptomatic although patients with muscular hypotonia developmental delay and seizures (among others) have been reported.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
2-methylbutyryl-CoA dehydrogenase deficiency?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

patriot for growth and development initiative

Patriots for Growth and Development Initiatives (PGDI), is a non-governmental and civil society organization that is dedicated to promoting sustainable development and poverty reduction in Nigeria and beyond. Founded in 2017 and registered with the Corporate Affairs Commission (CAC) in Nigeria, PGDI is committed to contributing to the attainment of the United Nations Millennium Development Goals

Clinical Trials

For a list of clinical trials in this disease area, please click here.